Cyclin-dependent kinase 5 (Cdk5) and its activator p35 have been implicated in drug addiction, neurodegenerative diseases such as Alzheimer's, learning and memory, and synapse maturation and plasticity. However, the molecular mechanisms by which Cdk5 regulates synaptic plasticity are still unclear. PSD-95 is a major postsynaptic scaffolding protein of glutamatergic synapses that regulates synaptic strength and plasticity. PSD-95 is ubiquitinated by the ubiquitin E3 ligase Mdm2, and rapid and transient PSD-95 ubiquitination has been implicated in NMDA receptor-induced AMPA receptor endocytosis. Here we demonstrate that genetic or pharmacological reduction of Cdk5 activity increases the interaction of Mdm2 with PSD-95 and enhances PSD-95 ubiquitination without affecting PSD-95 protein levels in vivo in mice, suggesting a nonproteolytic function of ubiquitinated PSD-95 at synapses. We show that PSD-95 ubiquitination correlates with increased interaction with ␤-adaptin, a subunit of the clathrin adaptor protein complex AP-2. This interaction is increased by genetic reduction of Cdk5 activity or NMDA receptor stimulation and is dependent on Mdm2. Together these results support a function for Cdk5 in regulating PSD-95 ubiquitination and its interaction with AP-2 and suggest a mechanism by which PSD-95 may regulate NMDA receptor-induced AMPA receptor endocytosis. . Author contributions: T.T.L. and M.A.M. designed research; M.J.B. and T.T.L. performed research; S.N.J. contributed unpublished reagents/analytic tools; M.J.B., T.T.L., and M.A.M. analyzed data; M.J.B., T.T.L., S.N.J., and M.A.M. wrote the paper.
Introduction
Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/ threonine kinase expressed in the CNS that, with its activator p35, is implicated in synaptic plasticity, learning and memory, drug addiction, and neurodegeneration (Angelo et al., 2006; Cheung et al., 2006; Lai and Ip, 2009 ). Cdk5 is inactivated following NMDA receptor stimulation or depolarization (Schuman and Murase, 2003; Wei et al., 2005) , and Cdk5's role in synaptic plasticity is underscored by enhanced long-term potentiation (LTP) in conditional Cdk5 knock-out mice and a lower threshold for LTP induction and impaired long-term depression (LTD) in p35 knock-out mice Wei et al., 2005) .
PSD-95 (SAP90) is a major postsynaptic scaffolding protein of glutamatergic synapses and a substrate of Cdk5 (Morabito et al., 2004) . PSD-95 has been implicated in synaptic maturation and regulation of synaptic strength and plasticity (Kim and Sheng, 2004; Funke et al., 2005; Béïque et al., 2006; Elias and Nicoll, 2007) . The importance of PSD-95 in synaptic plasticity is under-scored by the inhibition of NMDA receptor (NMDAR)-induced AMPA receptor (AMPAR) internalization and the impairment of LTD following PSD-95 knockdown (Xu et al., 2008; Bhattacharyya et al., 2009) . The rapid and transient ubiquitination of PSD-95 by the ubiquitin E3 ligase Mdm2 has been implicated in NMDAR-induced endocytosis of AMPARs (Colledge et al., 2003) , but the mechanisms regulating this posttranslational modification of PSD-95 are still unclear.
Since Cdk5 is inactivated by NMDAR stimulation (Wei et al., 2005) , we investigated whether inactivation of Cdk5 promotes PSD-95 ubiquitination. In this study we report that PSD-95 is ubiquitinated in neurons with reduced Cdk5 activity without affecting PSD-95 protein levels in vivo. We also show that PSD-95 ubiquitination correlates with increased interaction of PSD-95 with ␤-adaptin, a subunit of the clathrin adaptor protein complex AP-2, and that this interaction is increased under reduced Cdk5 activity or by NMDAR stimulation and is dependent on Mdm2. Together these results suggest a nonproteolytic signaling function for PSD-95 ubiquitination and support a novel function for Cdk5 in the regulation of glutamatergic synapses.
Materials and Methods
Mice. Adult p35 knock-out mice and control littermates were gifts from Dr. Li-Huei Tsai (Massachusetts Institute of Technology, Cambridge, MA). Mdm2/p53 double knock-out mice, p53 knock-out mice, and p35 knock-out mice have been described previously (Donehower et al., 1992; Jones et al., 1995; Chae et al., 1997) . All mice were bred and analyzed in accordance with institutional guidelines and as approved by the Institutional Animal Care and Use Committee of the University of Massachusetts Medical School, Worcester, MA.
Acute forebrain slices. Acute forebrain slices were prepared as described previously (Zhang et al., 2008) . Briefly, brains of adult wild-type mice of either sex were isolated, and 300 m coronal slices of forebrain (within the region corresponding approximately to Ϫ1.0 to Ϫ3.5 mm from bregma, containing the hippocampus) were prepared using a Vibratome (VT1000S; Leica Microsystems) in ice-cold oxygenated artificial CSF (ACSF) containing the following (in mM): 117 NaCl, 1.7 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 , and 11.5 glucose. Slices were preincubated in ACSF for 1 h before treatments and all experiments were conducted at 32°C in 95% O 2 and 5% CO 2 incubator. Slice lysates were prepared as described previously (Zhang et al., 2008) , and PSD-95 immunoprecipitated from the lysates was analyzed by Western blot and quantified as described above. Values are expressed as mean Ϯ SEM and were statistically compared using Student's t test or a two-way ANOVA.
Western blots of brain lysates. Brain lysates were prepared according to Zhang et al., (2008) . Briefly, brains (without cerebellum) were first homogenized and lysed in 1% deoxycholate (DOC) lysis buffer (150 mM NaCl, 50 mM Tris, pH 8.8, 1% DOC), to which an equal volume of modified RIPA was added (150 mM NaCl, 50 mM Tris/HCl, pH 7.4, 1 mM EDTA, 1% Triton X-100, 0.1% SDS) (Kalia et al., 2006) . All buffers were supplemented with protease and phosphatase inhibitor cocktails (Roche). Lysate protein concentrations were determined by Detergent Compatible Protein Assay (Bio-Rad). Immunoprecipitations and Western blot analysis were performed as described previously (Zhang et al., 2008) . Antibodies used were mouse monoclonals Mdm2 (Millipore), PSD-95 (Antibodies Incorporated); ubiquitin (BD Transduction), FK1 (Biomol/Enzo Life Sciences), and FK2 (Biomol/Enzo Life Sciences). Western blots were visualized by enhanced chemiluminescence (GE Healthcare), and immunoreactive bands were digitally scanned and quantified with ImageJ software (NIH). Coimmunoreactivity was normalized to the level of immunoprecipitated PSD-95 and expressed as a percentage of control levels. Values are expressed as mean Ϯ SEM and were statistically compared using Student's t test.
Mass spectrometry. PSD-95 was immunoprecipitated from acute mouse forebrain slices treated with roscovitine as described above (Acute forebrain slices). Each eluted protein sample was reduced and alkylated, digested with either LysC/Trypsin or GluC/Trypsin, and phosphoenriched with an in-house developed TiO 2 enrichment strategy (Rinehart et al., 2009) to optimize for the observed Ͼ80% sequence coverage, which encompasses 29 of the 38 lysines in mouse PSD-95. Both flowthrough and phosphoenriched fractions were injected onto a C18 RP Atlantis column attached to a nanoACQUITY UPLC system in line with a hybrid LTQ or Velos Orbitrap LC MS/MS instrument. Collected raw data from 13 experiments were processed by Distiller software (Matrix Science) and searched with the MASCOT search engine. Ubiquitinated sites were identified by the addition of a Gly-Gly moiety on lysines and were manually validated.
Dissociated hippocampal cultures and immunocytochemistry. Dissociated hippocampal cultures were prepared from E17-E18 rat brains as described previously (Zhang et al., 2008) . Hippocampal neurons were plated on coverslips coated with poly-D-lysine and laminin at a density of 6600/cm 2 and grown in Neurobasal medium supplemented with B27 and GlutaMax (Invitrogen) for 17-21 d in vitro. Cultures were treated for 45 min with 10 M roscovitine or DMSO as a control, fixed in 4% paraformaldehyde, 5% sucrose in PBS for 15 min, and then permeabilized in blocking buffer (10% BSA, 0.2% Triton X-100 in PBS) for 1 h. Cultures were then stained using rabbit polyclonal PSD-95 antibody (Zymed) together with mouse monoclonal antibody Mdm2 (Millipore) or ␤-adaptin (BD Transduction Laboratories) and secondary antibodies (Alexa 488-and Alexa 594-conjugated; Invitrogen), and mounted in Vectashield (Vector Laboratories). Omission of primary antibody was used as the control for specificity of staining. Each experimental treatment and analysis was performed blind using raw images from three experiments and six coverslips. Images were captured using a Leica TCS laser-scanning confocal microscope under identical conditions (63ϫ objective, 1024 ϫ 1024 pixel format, and identical settings). Images from each experiment (n) were thresholded using identical values and analyzed by MetaMorph software. The number of costained puncta, as percentage of total PSD-95 puncta, was expressed as a percentage of the number for DMSO controls. The colocalization was expressed as mean Ϯ SEM and statistically compared using Student's t test.
Results

Decreased Cdk5 activity increases PSD-95 ubiquitination
To assess whether Cdk5 regulates PSD-95 ubiquitination, we analyzed the levels of PSD-95 ubiquitination in p35 knock-out mice, which have reduced Cdk5 activity by 78% (Hallows et al., 2006) . Immunoblotting of PSD-95 immunoprecipitated from brain revealed a more than fourfold increase in PSD-95 ubiquitination in p35 knock-out mice compared to wild-type littermates (431.3 Ϯ 84.4% vs 100 Ϯ 18.5% for wild type; n ϭ 3; p Ͻ 0.05; Fig.  1 A) , with a pattern of discrete bands closely resembling those observed by Colledge et al. (2003) . We also determined the levels of PSD-95 ubiquitination in acute mouse forebrain slices in which Cdk5 was inhibited pharmacologically by treatment with the Cdk5 inhibitor roscovitine (Fig. 1 B) . Consistent with the increase in PSD-95 ubiquitination observed in p35 knock-out mice, pharmacological inhibition of Cdk5 by roscovitine resulted in a more than twofold increase in PSD-95 ubiquitination (274.6 Ϯ 71.6% vs 100 Ϯ 54.5% for untreated control; n ϭ 4; p Ͻ 0.01). Together, these data indicate that decreased Cdk5 activity results in increased PSD-95 ubiquitination.
PSD-95 contains multiple protein-protein interaction motifs including an N-terminal domain, three PDZ domains, an SH3 Figure 1. Reduced Cdk5 activity promotes PSD-95 ubiquitination. A, p35 knock-out mice have increased PSD-95 ubiquitination. Immunoblots of PSD-95 immunoprecipitated from brain lysates of wild-type (ϩ/ϩ) and p35 knock-out (Ϫ/Ϫ) mice revealed discrete bands representing increased PSD-95 ubiquitination in p35 knock-out mice. Quantification (mean Ϯ SEM) revealed that ubiquitination of PSD-95 was 431.3 Ϯ 84.4% versus 100 Ϯ 18.5% for wild type (n ϭ 3; p Ͻ 0.05). The ubiquitin immunoreactivity was normalized to the level of immunoprecipitated PSD-95 and expressed as a percentage of wild-type control. B, Roscovitine treatment increases PSD-95 ubiquitination.AcutemouseforebrainslicesweretreatedwiththeCdk5inhibitorroscovitine(10M,45min)or DMSO as the control. Immunoblots of PSD-95 immunoprecipitated from lysates revealed increased ubiquitination of PSD-95 in roscovitine-treated (R) slices relative to control (D), with a pattern of discrete bands similar to that obtained in p35 knock-out mice. Quantification revealed that ubiquitination of PSD-95 was 274.6 Ϯ 71.6% with roscovitine treatment versus 100 Ϯ 54.5% in untreated control (n ϭ 4; p Ͻ 0.01). Ubiquitin immunoreactivity was normalized to the level of immunoprecipitated PSD-95 and expressed as a percentage of DMSO control. C, PSD-95 is ubiquitinated on multiple lysines. PSD-95 immunoprecipitated from acute mouse forebrain slices treated with the Cdk5 inhibitorroscovitine(10M,45min)wassubjectedtoLCMS/MSanalysis.Peptidesobtainedcovered Ͼ80%ofthePSD-95primaryaminoacidsequence(DLG4,mouse;Swiss-Protdatabase).Aschematic view of PSD-95 domain structure with ubiquitinated lysines (K) is shown. Lysine residues ubiquitinated are K 10 in the N terminus, K 403 in the linker between the PDZ3 and SH3 domains, and K 544, K 672, and K 679 in the GK domain.
(Src homology 3) domain, and a GK (guanylate kinase) domain (Kim and Sheng, 2004; Montgomery et al., 2004) . To identify the ubiquitinated lysines on PSD-95, we performed high-resolution tandem mass spectrometry analysis on PSD-95 immunoprecipitated from acute mouse forebrain slices treated with roscovitine. High molecular weight (MW) and long peptides generally pose difficulty in collision-induced dissociation-type fragmentation by most tandem mass spectrometers. Based on theoretically predicted digestion using various enzymes, we found that by including either GluC (Staphylococcus aureus protease V8) or LysC (endoproteinase from Lysobacter enzymogenes) with a trypsin digestion of PSD-95, we eliminated all the high MW peptides (peptides with MW Ͼϳ3500) generated from just using trypsin. The combination of GluC or LysC with trypsin digestion resulted in Ͼ80% primary protein sequence coverage of PSD-95 (DLG4, mouse; Swiss-Prot database), overlapping 29 of the 38 lysines, with Lys 152, Lys 157, Lys 162, Lys 165, Lys 211, Lys 355, Lys 503, Lys 505, and Lys 624, not represented. The presence of a Gly-Gly moiety on a lysine residue corresponds to the C terminus of the ubiquitin tag, which is present when trypsin (or a combination of GluC/trypsin enzymes) is used for enzymatic digestion before LC MS/MS analysis, and is indicative of ubiquitination. We identified five lysine residues of PSD-95 that were ubiquitinated after roscovitine treatment (Fig. 1C) : Lys 10 in the N terminus, Lys 403 in the linker between PDZ3 and SH3 domains, and Lys 544, Lys 672, and Lys 679 in the GK domain. These results indicate that, under decreased Cdk5 activity, the N terminus as well as the PDZ3/SH3 linker region and the GK domain are ubiquitinated.
Mdm2 has been identified as the ubiquitin ligase for PSD-95 (Colledge et al., 2003) . Since the ubiquitination of PSD-95 is dependent on Mdm2, the increase in PSD-95 ubiquitination that we observed under reduced Cdk5 activity could reflect an increased interaction of PSD-95 with Mdm2. To investigate whether Cdk5 activity inversely correlates with the level of interaction of PSD-95 with Mdm2, we analyzed PSD-95 immunoprecipitated from brain lysates of p35 knock-out mice and wild-type littermates by immunoblotting with an Mdm2 antibody ( Fig.  2 A) . Consistent with the increase in PSD-95 ubiquitination, the interaction of Mdm2 with PSD-95 increased more than threefold in p35 knock-out mice compared to wild type (360.5 Ϯ 65.6% vs 100 Ϯ 20.6% for wild type; n ϭ 3; p Ͻ 0.05). To further assess whether Cdk5 regulates the level of PSD-95 association with Mdm2, we analyzed roscovitine-treated cultured hippocampal neurons by immunocytochemistry (Fig. 2B ). We found that roscovitine treatment increased the colocalization of Mdm2 with PSD-95 puncta compared to DMSO control sister cultures (149 Ϯ 27.4% vs 100 Ϯ 24.8% for control; n ϭ 4; p Ͻ 0.05). Together these data indicate that decreased Cdk5 activity increases colocalization and interaction of Mdm2 with PSD-95, thus promoting PSD-95 ubiquitination by Mdm2.
Decreased Cdk5 activity increases PSD-95 ubiquitination without a decrease in PSD-95 protein levels
Ubiquitination may occur by the addition of a single ubiquitin moiety to one or multiple lysine residues (monoubiquitination) or by addition of polymeric ubiquitin chains (polyubiquitination) (DiAntonio and Hicke, 2004; d'Azzo et al., 2005) . While Mdm2 can catalyze both monoubiquitination and polyubiquitination (Li et al., 2003) , the discrete ubiquitinated PSD-95 species that we observe and that were originally identified by Colledge et al. (2003) suggest PSD-95 monoubiquitination on multiple sites. The FK1 and FK2 monoclonal antibodies are used to differentiate between monoubiquitination and polyubiquitination, since FK2 detects both monoubiquitinated and polyubiquitinated proteins, while FK1 recognizes only polyubiquitinated proteins (Fujimuro et al., 1994) . Therefore, to assess whether the ubiquitination of PSD-95 reflects monoubiquitination or polyubiquitination, we tested PSD-95 from p35 knock-out mice for immunoblotting with FK1 and FK2 antibodies. Immunoblotting of PSD-95 immunoprecipitated from p35 knock-out brain revealed that PSD-95 ubiquitination is detected by FK2, not FK1. Polyubiquitinated species observed in the input lanes serve as a positive control for FK1 immunoreactivity (Fig. 3A) . Similar results were obtained with PSD-95 immunoprecipitated from roscovitinetreated acute forebrain slices (Fig. 3B) . The immunoreactivity of PSD-95 to FK2 but not to FK1 suggests monoubiquitination of PSD-95 on multiple lysines and is consistent with the LC MS/MS results.
While polyubiquitination has been mainly associated with targeting of proteins for degradation by the 26S proteasome, monoubiquitination has been implicated in nonproteasomal signaling functions (Hicke and Dunn, 2003; DiAntonio and Hicke, 2004; d'Azzo et al., 2005; Chen and Sun 2009) . To assess the relationship between PSD-95 ubiquitination and degradation, we analyzed the levels of PSD-95 in brain lysates of p35 knock-out and wild-type mice ( Fig. 3C ) and in roscovitine-treated and control acute forebrain slices (Fig. 3D) . We observed no significant change in PSD-95 protein levels (normalized to actin) in p35 knock-out mice compared to wild-type littermates (120.7 Ϯ 30.5% vs 100 Ϯ 15.7% for wild type; n ϭ 4; p Ͼ 0.5) or in roscovitine-treated slices compared to control (103.7 Ϯ 18.7% vs 100 Ϯ 15.8% for control; n ϭ 3; p Ͼ 0.5). Thus, these results indicate that PSD-95 ubiquitination does not directly correlate with decreased PSD-95 protein levels, suggesting a nonproteolytic function for ubiquitinated PSD-95 at the synapse. 
PSD-95 ubiquitination promotes the interaction with the clathrin endocytic adaptor complex AP-2
AMPAR endocytosis is mediated by the clathrin endocytic adaptor complex AP-2 (Carroll et al., 1999; Man et al., 2000) . While the function of PSD-95 in AMPAR endocytosis is not clear, it has been shown that PSD-95 interacts with the AP-2 complex (Fernandez et al., 2009) , and the AP-2 binding motif (YXX⌽) within the GK domain of PSD-95 (Y 701 HKV) is sufficient to mediate clathrin-dependent endocytosis of the transmembrane protein Tac (Craven and Bredt, 2000) . Therefore, we hypothesize that PSD-95 ubiquitination functions by regulating the interaction of PSD-95 with the AP-2 complex.
Since p35 knock-out mice have increased PSD-95 ubiquitination, we used these mutant mice to assess whether PSD-95 ubiquitination correlates with changes in PSD-95 interaction with AP-2 in vivo. We analyzed the interaction of PSD-95 with AP-2 in brain lysates of p35 knock-out and wild-type littermates by immunoblotting immunoprecipitated PSD-95 for the AP-2 subunit ␤-adaptin ( Fig. 4 A) . The interaction of PSD-95 with ␤-adaptin was significantly increased in p35 knock-out mice (265 Ϯ 55.8%) versus wild type (100 Ϯ 16.4%; n ϭ 4; p Ͻ 0.05). We also analyzed whether ␤-adaptin colocalizes with PSD-95 puncta in cultured hippocampal neurons treated with roscovitine ( Fig. 4 B) . Immunocytochemistry analysis of these neurons revealed that roscovitine treatment promotes colocalization of ␤-adaptin with PSD-95 puncta compared to DMSO-treated control sister neurons (192.5 Ϯ 19% vs 100 Ϯ 15.6% for control; n ϭ 5; p Ͻ 0.01). Thus, these data indicate that decreased Cdk5 activity, which promotes PSD-95 ubiquitination, also promotes the interaction of PSD-95 with ␤-adaptin. To further assess whether PSD-95 ubiquitination regulates the interaction with AP-2, we analyzed PSD-95 immunoprecipitated from brain lysates of Mdm2/p53 double knock-out mice, since Mdm2 knock-out mice die early in development (Jones et al., 1995) , and control p53 knock-out mice (Fig. 4C ). Immunoblot analysis of Mdm2/p53 double knock-out brain lysates revealed decreased interaction of PSD-95 with ␤-adaptin compared to control p53 knock-out mice (63.7 Ϯ 8.8% vs 100 Ϯ 10.8% for control; n ϭ 5; p Ͻ 0.05). Together, these results indicate a correlation between the genetic deletion of Mdm2 and the decrease in PSD-95 interaction with ␤-adaptin and, conversely, between decreased Cdk5 activity and increased PSD-95 interaction with ␤-adaptin. Therefore, these results support a correlation between PSD-95 ubiquitination and interaction with ␤-adaptin, suggesting a function for ubiquitinated PSD-95 in the regulation of its interaction with the AP-2/clathrin endocytic complex.
PSD-95 ubiquitination is also induced by NMDA treatment (Colledge et al., 2003) ; thus, we investigated whether NMDA treatment regulates the interaction of PSD-95 with ␤-adaptin. Acute forebrain slices from adult wild-type mice were treated with NMDA (100 M, 3 min), a treatment that induces AMPAR endocytosis (Bhattacharyya et al., 2009) , and analyzed at 5 and 10 min after NMDA washout. Immunoblot analysis of PSD-95 immunoprecipitated from the lysates revealed an increase in both PSD-95 ubiquitination and interaction with ␤-adaptin 10 min after NMDA washout (Fig. 4 D) . To further assess the correlation between PSD-95 ubiquitination and interaction with ␤-adaptin, we analyzed acute brain slices of adult Mdm2/p53 double knockout mice and control p53 knock-out mice 5 and 10 min after NMDA (100 M, 3 min) washout (Fig. 4 E) . Immunoblot analysis of PSD-95 immunoprecipitated from lysates of control p53 knock-out mice revealed an increase in PSD-95 interaction with ␤-adaptin at 5 min (209.0 Ϯ 72.6%; n ϭ 3) and 10 min (549.8 Ϯ 168%; n ϭ 3) after washout compared to the unstimulated control condition (100 Ϯ 14.9%; n ϭ 3). In contrast, the interaction of PSD-95 with ␤-adaptin was consistently lower in Mdm2/p53 double knock-out slices in unstimulated conditions (50.5 Ϯ 13.8%; n ϭ 3) at 5 min (45.6 Ϯ 1.8%; n ϭ 3) and 10 min (99.8 Ϯ 43.7%; n ϭ 3) after NMDA washout compared to unstimulated p53 knock-out control conditions. All the values obtained for the PSD-95/␤-adaptin interaction in p53 and Mdm2/p53 double knock-outs were statistically significant (p Ͻ 0.005, ANOVA). These results indicate that the interaction of PSD-95 with ␤-adaptin is regulated by NMDARs and depends on Mdm2 expression. Thus, together these data support a direct correlation Figure 3 . Ubiquitination of PSD-95 does not alter PSD-95 protein levels. A, PSD-95 is monoubiquitinated on multiple lysines in p35 knock-out mice. PSD-95 immunoprecipitated from brain lysates of wild-type (ϩ/ϩ) and p35 knock-out (Ϫ/Ϫ) mice immunoblotted with the FK2 antibody, which recognizes polyubiquitinated and monoubiquitinated proteins. FK2 immunoblot analysis revealed increased PSD-95 ubiquitination in p35 knock-out mice, with the same pattern of discrete bands observed with the ubiquitin antibody. Immunoblot with the FK1 antibody, which recognizes only polyubiquitinated proteins, did not reveal immunoreactive bands (right). Immunoblotting of polyubiquitinated proteins in the input serves as a positive control for FK1. B, Roscovitine treatment increases PSD-95 monoubiquitination on multiple lysines. Acute mouse forebrain slices were treated with the Cdk5 inhibitor roscovitine (R; 10 M, 45 min) or DMSO (D) as a control. Immunoblots of PSD-95 immunoprecipitated from lysates of the treated slices revealed FK2 immunoreactivity with a pattern of discrete bands similar to that obtained in p35 knock-out mice. FK1 immunoblots did not reveal immunoreactive bands from immunoprecipitated PSD-95 as for the p35 knock-out mice (right). Immunoblotting of polyubiquitinated proteins in the input serves as a positive control for FK1. C, PSD-95 ubiquitination does not alter PSD-95 protein levels. Brain lysates from wild-type (ϩ/ϩ) and p35 knock-out (Ϫ/Ϫ) mice were immunoblotted for PSD-95 and actin. Quantification (mean Ϯ SEM) revealed that PSD-95 protein levels in the p35 knock-out mice were 120.7 Ϯ 30.5% versus 100 Ϯ 15.7% for wild type (n ϭ 4; p Ͼ 0.5). PSD-95 immunoreactivity was normalized to actin and expressed as a percentage of wild-type control mice. D, Roscovitine treatment does not affect the protein levels of PSD-95. Brain lysates from acute mouse forebrain slices treated with the Cdk5 inhibitor roscovitine (10 M, 45 min) or DMSO as control were immunoblotted for PSD-95 and actin. Quantification revealed that PSD-95 protein levels in the roscovitine samples were 103.7 Ϯ 18.7% versus 100 Ϯ 15.8% for DMSO controls (n ϭ 3; p Ͼ 0.5). PSD-95 immunoreactivity was normalized to actin and expressed as a percentage of DMSO control levels.
between PSD-95 ubiquitination and interaction with AP-2, suggesting that PSD-95 ubiquitination may function in NMDARdependent AMPAR endocytosis by regulating the interaction with the clathrin endocytic adaptor complex AP-2.
SH3 and GK domains are linked by a pair of antiparallel strands and form an integrated structural unit (McGee et al., 2001; Tavares et al., 2001) . Lys 544, Lys 672, and Lys 679 are within ␣ helix structures of the GK domain, suggesting that ubiquitination of these residues may change the conformation of the SH3/GK domain through the sterical presence of the ubiquitin moiety, making PSD-95 more accessible for protein interactions. In addition, the SH3 and GK domains are important for the localization of PSD-95 at the PSD, and hence for the effect of PSD-95 on AMPAR EPSCs (Xu et al., 2008) . Thus, addition of ubiquitin moieties to these domains may regulate PSD-95 protein interactions, the organization of signaling molecules and cytoskeletal elements, and the strength of synaptic transmission.
In our study, PSD-95 ubiquitination does not correlate with its degradation both in p35 knock-out brain in vivo and in roscovitine-treated neurons, and is consistent with PSD-95 monoubiquitination. Previous studies have associated PSD-95 ubiquitination with its proteasomal degradation by showing that deletion of the PEST motif in PSD-95 or treatment with the proteasome inhibitor MG132 (C 26 H 41 N 3 O 5 ) protects PSD-95 from degradation (Colledge et al., 2003) . Interestingly, the proteases calpain and caspase can catalyze PSD-95 degradation (Lu et al., 2000; Vinade et al., 2001; Gascó n et al., 2008; Liu et al., 2010) , and MG132 is also an inhibitor of calpains (Lee and Goldberg, 1998; Elliott et al., 2003) . Furthermore, Lys 10 in PSD-95, which is ubiquitinated under reduced Cdk5 activity, is adjacent to the PEST motif, which has been implicated in proteolysis by caspases (Belizario et al., 2008) and calpains (Rechsteiner and Rogers, 1996; Shumway et al., 1999) .
Our studies suggest a novel function for ubiquitinated PSD-95 at the synapse in the regulation of PSD-95 interaction with the clathrin endocytic adaptor complex AP-2. We observe a correlation between reduction of Cdk5 activity, increased PSD-95 ubiquitination, and increased PSD-95 interaction with ␤-adaptin, a component of AP-2/clathrin adaptor protein complex. We also observe the NMDAR-dependent increase in PSD-95 ubiquitination, first described by Colledge et al., (2003) , accompanied by the increase in PSD-95 interaction with ␤-adaptin. The correlation between PSD-95 ubiquitination and increased interaction with AP-2 is further supported by our observation that, whereas in p53 knock-out mice NMDAR activity induces an increase in PSD-95 interaction with ␤-adaptin, this increase is greatly reduced in mice with a genetic deletion of Mdm2. Our results are consistent with previous studies indicating an interaction between PSD-95 and AP-2 (Fernandez et al., 2009 ) and a function for the motif within the GK domain of PSD-95 in mediating the clathrin-dependent endocytosis of the transmembrane protein Tac (Craven and Bredt, 2000) . Together these observations suggest that ubiquitinated PSD-95 functions in recruiting the clathrin/AP-2 endocytic complex and possibly regulating the interaction with other postsynaptic proteins. Our data demonstrate that Cdk5 regulates the ubiquitination of PSD-95 and its interaction with AP-2. Given that ubiquitination of PSD-95 has been implicated in NMDAR-induced endocytosis of AMPARs, the recruitment of the clathrin/AP-2 endocytic complex by PSD-95 could provide a mechanism by which Cdk5 could modulate AMPAR internalization during synaptic plasticity.
